Literature DB >> 24494173

Homozygous Deletion of Glutathione Peroxidase 1 and Aldehyde Dehydrogenase 1a1 Genes Is Not Associated with Schizophrenia-Like Behavior in Mice.

Xiang Bai1, Elizabeth Fermandez2, Georgianna Gould3, Randy Strong2.   

Abstract

Much evidence suggests that oxidative stress plays a role in schizophrenia pathogenesis. Major oxidative stress sources include hydrogen peroxide and biogenic aldehydes that are mainly cleared in vivo by glutathione peroxidase (GPX) and aldehyde dehydrogenase (ALDH), respectively. Both enzymes are richly expressed in brain. Schizophrenia patients have significantly increased plasma levels of malondialdehyde and glutathione, combined with decreased GPX activity and ALDH1 mRNA levels in the ventral tegmental area. Absence of Aldh1a1 (murine homolog of ALDH1) gene causes increased basal extracellular dopamine concentrations, a common characteristic of schizophrenia. Studies investigating association between gene polymorphisms of GPX1 (the most abundant form of GPX) or ALDH1A1 with schizophrenia also have not clearly demonstrated whether ALDH1A1 or GPX1 is involved in pathogenesis of schizophrenia. To investigate possible contributions of ALDH and GPX to pathological behaviors associated with schizophrenia, we generated mice with both Aldh1a1 and Gpx1 gene deletions (KO). Aldh1a1/Gpx1 KO and wild type (WT) mice had similar number of novel entry and alteration in Y-maze test, suggesting no cognition deficit in KO. Furthermore, KO and WT displayed similar social interaction and novelty preferences in three chambered tests. Overall, KO and WT had similar activity levels, as indicated by their entries in the Y-maze and sociability tests. Furthermore both genotypes buried a similar percentage of marbles in a 30 min marble-burying task. In summary, homozygous deletion of Gpx1 and Aldh1a1 genes was not associated with schizophrenia-like behavioral phenotypes including anxiety, hyperactivity, cognitive deficit or social disability. Our findings suggest that constitutive absence of these genes alone is unlikely to give rise to common behavioral schizophrenia symptoms. However, these mice may be highly sensitive to oxidative challenges during critical stages of prenatal or juvenile brain development.

Entities:  

Keywords:  aldehyde dehydrogenase 1a1 (Aldh1a1); gene deletion; glutathione peroxidase 1 (Gpx1); oxidative stress; schizophrenia

Year:  2013        PMID: 24494173      PMCID: PMC3909525     

Source DB:  PubMed          Journal:  J Biochem Pharmacol Res


  44 in total

1.  Prefrontal cortical dysfunction during visual perspective-taking in schizophrenia.

Authors:  Shaun M Eack; Jessica A Wojtalik; Christina E Newhill; Matcheri S Keshavan; Mary L Phillips
Journal:  Schizophr Res       Date:  2013-09-19       Impact factor: 4.939

Review 2.  Free radical pathology and antioxidant defense in schizophrenia: a review.

Authors:  S P Mahadik; S Mukherjee
Journal:  Schizophr Res       Date:  1996-03       Impact factor: 4.939

3.  Body mass index of inpatients with schizophrenia in Japan.

Authors:  Yukiko Inamura; Toyoaki Sagae; Kenichi Nakamachi; Nobuko Murayama
Journal:  Int J Psychiatry Med       Date:  2012       Impact factor: 1.210

4.  Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.

Authors:  A Breier; T P Su; R Saunders; R E Carson; B S Kolachana; A de Bartolomeis; D R Weinberger; N Weisenfeld; A K Malhotra; W C Eckelman; D Pickar
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 5.  Imaging dopamine transmission in schizophrenia. A review and meta-analysis.

Authors:  M Laruelle
Journal:  Q J Nucl Med       Date:  1998-09

Review 6.  Regulation of enzymatic lipid peroxidation: the interplay of peroxidizing and peroxide reducing enzymes.

Authors:  Hartmut Kühn; Astrid Borchert
Journal:  Free Radic Biol Med       Date:  2002-07-15       Impact factor: 7.376

7.  Association study between the genetic polymorphisms of glutathione-related enzymes and schizophrenia in a Japanese population.

Authors:  Daisuke Matsuzawa; Kenji Hashimoto; Tasuku Hashimoto; Eiji Shimizu; Hiroyuki Watanabe; Yuko Fujita; Masaomi Iyo
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-01-05       Impact factor: 3.568

Review 8.  The hippocampus and nucleus accumbens as potential therapeutic targets for neurosurgical intervention in schizophrenia.

Authors:  Charles B Mikell; Guy M McKhann; Solomon Segal; Robert A McGovern; Matthew B Wallenstein; Holly Moore
Journal:  Stereotact Funct Neurosurg       Date:  2009-06-26       Impact factor: 1.875

Review 9.  Neuroinflammation and psychiatric illness.

Authors:  Souhel Najjar; Daniel M Pearlman; Kenneth Alper; Amanda Najjar; Orrin Devinsky
Journal:  J Neuroinflammation       Date:  2013-04-01       Impact factor: 8.322

Review 10.  So depression is an inflammatory disease, but where does the inflammation come from?

Authors:  Michael Berk; Lana J Williams; Felice N Jacka; Adrienne O'Neil; Julie A Pasco; Steven Moylan; Nicholas B Allen; Amanda L Stuart; Amie C Hayley; Michelle L Byrne; Michael Maes
Journal:  BMC Med       Date:  2013-09-12       Impact factor: 8.775

View more
  3 in total

1.  Neurochemical and motor changes in mice with combined mutations linked to Parkinson's disease.

Authors:  Xiang Bai; Margaret Chia-Ying Wey; Paul Anthony Martinez; Chao Shi; Elizabeth Fernandez; Randy Strong
Journal:  Pathobiol Aging Age Relat Dis       Date:  2017-01-05

2.  Oxidative stress biomarkers in treatment-responsive and treatment-resistant schizophrenia patients.

Authors:  Patrick Buosi; Fábio Aparecido Borghi; Angélica Marta Lopes; Isabela da Silva Facincani; Rafael Fernandes-Ferreira; Camila Ive Ferreira Oliveira-Brancati; Tayanne Silva do Carmo; Dorotéia Rossi Silva Souza; Danilo Grünig Humberto da Silva; Eduardo Alves de Almeida; Gerardo Maria de Araújo Filho
Journal:  Trends Psychiatry Psychother       Date:  2021-01-01

3.  DNA damage and synaptic and behavioural disorders in glucose-6-phosphate dehydrogenase-deficient mice.

Authors:  Margaret M Loniewska; Anmol Gupta; Shama Bhatia; Isabel MacKay-Clackett; Zhengping Jia; Peter G Wells
Journal:  Redox Biol       Date:  2019-09-18       Impact factor: 11.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.